Related Experiment Video
Updated: Aug 8, 2026

Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
Published on: June 14, 2020
Soluble ICAM-1 levels in serum during acute infectious mononucleosis
S Furukawa1, T Motohashi, T Matsubara
1Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.
Insights
Soluble intercellular adhesion molecule-1 (ICAM-1) levels rise during acute infectious mononucleosis (IM). This increase correlates with more activated immune cells, suggesting ICAM-1 regulates immune responses in IM.
Area of Science:
- Immunology
- Virology
- Biochemistry
Background:
- Intercellular adhesion molecule-1 (ICAM-1) is recognized as an activation antigen on immune cells like T-cells, B-cells, macrophages, and monocytes.
- Understanding the role of ICAM-1 in viral infections is crucial for immune response modulation.
Purpose of the Study:
- To investigate the levels of soluble ICAM-1 in serum during the acute phase of infectious mononucleosis (IM).
- To explore the correlation between serum ICAM-1 levels and peripheral blood mononuclear cell counts in IM patients.
Main Methods:
- Serum samples were collected from 11 patients during the acute stage of IM.
- Soluble ICAM-1 levels were quantified using a double determinant immunoassay with monoclonal antibodies on the FAST system.
Main Results:
- Serum ICAM-1 levels were significantly elevated in patients during the acute stage of IM.
- A positive correlation was observed between increased serum ICAM-1 levels and higher absolute counts of peripheral blood mononuclear cells.
Conclusions:
- Elevated serum ICAM-1 levels in acute IM are associated with an increased number of activated peripheral blood mononuclear cells.
- ICAM-1 appears to play a role in the regulatory mechanisms of immune reactions during acute infectious mononucleosis.
Abstract:
Intercellular adhesion molecule-1 (ICAM-1) has been reported as a T-cell, B-cell or macrophage/monocyte activation antigen. We investigated whether soluble ICAM-1 levels in serum increased during the acute stage in 11 patients with infectious mononucleosis (IM). Serum ICAM-1 levels were measured by a double determinant immunoassay using 2 monoclonal antibodies in the FAST system. Serum ICAM-1 levels in patients with IM increased during the acute stage. There was a positive correlation between serum ICAM-1 levels and absolute counts of peripheral blood mononuclear cells. Our results suggest that the elevated serum ICAM-1 levels are based on the increased counts of activated peripheral blood mononuclear cells and that ICAM-1 is a part of the regulatory system of immune reactions during acute IM.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Acute Inflammation II: Cellular Phase

